These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 31706979)

  • 1. Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function.
    Sun Y; Zhou S; Guo H; Zhang J; Ma T; Zheng Y; Zhang Z; Cai L
    Metabolism; 2020 Jan; 102():154002. PubMed ID: 31706979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulforaphane prevents type 2 diabetes-induced nephropathy via AMPK-mediated activation of lipid metabolic pathways and Nrf2 antioxidative function.
    Li Z; Guo H; Li J; Ma T; Zhou S; Zhang Z; Miao L; Cai L
    Clin Sci (Lond); 2020 Sep; 134(18):2469-2487. PubMed ID: 32940670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway.
    Zhang Z; Wang S; Zhou S; Yan X; Wang Y; Chen J; Mellen N; Kong M; Gu J; Tan Y; Zheng Y; Cai L
    J Mol Cell Cardiol; 2014 Dec; 77():42-52. PubMed ID: 25268649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy.
    Gu J; Cheng Y; Wu H; Kong L; Wang S; Xu Z; Zhang Z; Tan Y; Keller BB; Zhou H; Wang Y; Xu Z; Cai L
    Diabetes; 2017 Feb; 66(2):529-542. PubMed ID: 27903744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
    Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
    Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt/GSK-3ß/Fyn pathway.
    Xin Y; Bai Y; Jiang X; Zhou S; Wang Y; Wintergerst KA; Cui T; Ji H; Tan Y; Cai L
    Redox Biol; 2018 May; 15():405-417. PubMed ID: 29353218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-O-methylhonokiol ameliorates type 2 diabetes-induced nephropathy in mice likely by activation of AMPK-mediated fatty acid oxidation and Nrf2-mediated anti-oxidative stress.
    Ma T; Zheng Z; Guo H; Lian X; Rane MJ; Cai L; Kim KS; Kim KT; Zhang Z; Bi L
    Toxicol Appl Pharmacol; 2019 May; 370():93-105. PubMed ID: 30876865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against diabetic cardiomyopathy is achieved using a combination of sulforaphane and zinc in type 1 diabetic OVE26 mice.
    Wang J; Wang S; Wang W; Chen J; Zhang Z; Zheng Q; Liu Q; Cai L
    J Cell Mol Med; 2019 Sep; 23(9):6319-6330. PubMed ID: 31270951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation.
    Bai Y; Cui W; Xin Y; Miao X; Barati MT; Zhang C; Chen Q; Tan Y; Cui T; Zheng Y; Cai L
    J Mol Cell Cardiol; 2013 Apr; 57():82-95. PubMed ID: 23353773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nrf2 expression and function, but not MT expression, is indispensable for sulforaphane-mediated protection against intermittent hypoxia-induced cardiomyopathy in mice.
    Zhou S; Wang J; Yin X; Xin Y; Zhang Z; Cui T; Cai J; Zheng Y; Liu Q; Cai L
    Redox Biol; 2018 Oct; 19():11-21. PubMed ID: 30096613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-O-methylhonokiol protects against diabetic cardiomyopathy in type 2 diabetic mice by activation of AMPK-mediated cardiac lipid metabolism improvement.
    Zheng Z; Ma T; Guo H; Kim KS; Kim KT; Bi L; Zhang Z; Cai L
    J Cell Mol Med; 2019 Aug; 23(8):5771-5781. PubMed ID: 31199069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Broccoli sprout extract prevents diabetic cardiomyopathy via Nrf2 activation in db/db T2DM mice.
    Xu Z; Wang S; Ji H; Zhang Z; Chen J; Tan Y; Wintergerst K; Zheng Y; Sun J; Cai L
    Sci Rep; 2016 Jul; 6():30252. PubMed ID: 27457280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulforaphane alleviates high fat diet-induced insulin resistance via AMPK/Nrf2/GPx4 axis.
    Zhang Y; Wu Q; Liu J; Zhang Z; Ma X; Zhang Y; Zhu J; Thring RW; Wu M; Gao Y; Tong H
    Biomed Pharmacother; 2022 Aug; 152():113273. PubMed ID: 35709656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Farrerol Alleviates Diabetic Cardiomyopathy by Regulating AMPK-Mediated Cardiac Lipid Metabolic Pathways in Type 2 Diabetic Rats.
    Tu J; Liu Q; Sun H; Gan L
    Cell Biochem Biophys; 2024 Sep; 82(3):2427-2437. PubMed ID: 38878100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sinapic acid ameliorates cardiac dysfunction and cardiomyopathy by modulating NF-κB and Nrf2/HO-1 signaling pathways in streptozocin induced diabetic rats.
    Raish M; Ahmad A; Bin Jardan YA; Shahid M; Alkharfy KM; Ahad A; Ansari MA; Abdelrahman IA; Al-Jenoobi FI
    Biomed Pharmacother; 2022 Jan; 145():112412. PubMed ID: 34768051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metallothionein plays a prominent role in the prevention of diabetic nephropathy by sulforaphane via up-regulation of Nrf2.
    Wu H; Kong L; Cheng Y; Zhang Z; Wang Y; Luo M; Tan Y; Chen X; Miao L; Cai L
    Free Radic Biol Med; 2015 Dec; 89():431-42. PubMed ID: 26415026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection by sulforaphane from type 1 diabetes-induced testicular apoptosis is associated with the up-regulation of Nrf2 expression and function.
    Jiang X; Bai Y; Zhang Z; Xin Y; Cai L
    Toxicol Appl Pharmacol; 2014 Sep; 279(2):198-210. PubMed ID: 24967692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bailcalin Protects against Diabetic Cardiomyopathy through Keap1/Nrf2/AMPK-Mediated Antioxidative and Lipid-Lowering Effects.
    Li R; Liu Y; Shan YG; Gao L; Wang F; Qiu CG
    Oxid Med Cell Longev; 2019; 2019():3206542. PubMed ID: 31354905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nrf2 prevents diabetic cardiomyopathy via antioxidant effect and normalization of glucose and lipid metabolism in the heart.
    Yang G; Zhang Q; Dong C; Hou G; Li J; Jiang X; Xin Y
    J Cell Physiol; 2024 Feb; 239(2):e31149. PubMed ID: 38308838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Nrf2 by Sulforaphane Inhibits High Glucose-Induced Progression of Pancreatic Cancer via AMPK Dependent Signaling.
    Chen X; Jiang Z; Zhou C; Chen K; Li X; Wang Z; Wu Z; Ma J; Ma Q; Duan W
    Cell Physiol Biochem; 2018; 50(3):1201-1215. PubMed ID: 30355942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.